Skip to content
Israeli Founders

biotech, healthtech

Kailo Pharma

Drug development to weaken traumatic memories for PTSD, from University of Haifa research

Total raised
$2.1M
Funding rounds
1

Kailo Pharma is an Israeli biotech and healthtech company1.

It has raised $2.1M across 1 funding round1; the most recent was a round of $2.1M1, announced Mar 22, 20261.

Funding history

1 round

Funding rounds raised by Kailo Pharma, newest first
RoundAnnouncedAmountLead investors
Undisclosed stageMar 22, 2026$2.1MNGT Healthcare II

Investors

Which Israeli startups are similar to Kailo Pharma?

Which startups share investors with Kailo Pharma?

Sources

  1. 1CTech, Mar 22, 2026. “Israeli startup seeks to redefine PTSD treatment with novel brain mechanism”

How much funding has Kailo Pharma raised?

Kailo Pharma has raised $2.1M across 1 funding round.

What was Kailo Pharma’s latest funding round?

Kailo Pharma’s most recent round was a round of $2.1M, announced Mar 22, 2026.

Who has invested in Kailo Pharma?

Investors in Kailo Pharma include NGT Healthcare II, Israel Innovation Authority and Carmel (University of Haifa).